Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients?

Wideochirurgia I Inne Techniki Maloinwazyjne

Volumn 9, Issue 1, 2014, Pages 31-39

  Kaska, Łukasz ^a   Kobiela, Jarek ^a   Proczko, Monika ^a   Stefaniak, Tomasz ^a   Śledziński, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Biliary limb; Laboratory remission; Roux en Y gastric bypass; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANASTOMOSIS LEAKAGE; ANEMIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BILIARY LIMB LENGTH; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM FISTULA; DIGESTIVE SYSTEM ULCER; DUMPING SYNDROME; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCISIONAL HERNIA; LIMB; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PNEUMONIA; PROSPECTIVE STUDY; PROTEIN CALORIE MALNUTRITION; REMISSION; REOPERATION; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL INFECTION; VOMITING; WEIGHT REDUCTION;

EID: 84898458658     PISSN: 18954588     EISSN: 22990054     Source Type: Journal    
DOI: 10.5114/wiitm.2014.40383     Document Type: Article

References (44)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2005: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31.
2. IDF Diabetes Atlas 2009, 2011.
3. Rubino F, Kaplan LM, Schauer PR, Cummings D; the Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit Consensus Conference. Recommendations for the evaluation and use of gastrointestinal surgery to treat T2DM. Ann Surg 2011; 251: 399-405.
4. Rubino F. Is type 2 diabetes operable intestinal disease? Diabetes Care 2008; 31 (Suppl. 2): 290-6.
5. Which surgical procedure should be carried out for T2DM. Presented at the IXth Meeting of the Surgical Continuing Education, University of Malaga, Malaga 17-19 February 2010.
6. Batsis JA, Sarr MG, Collazo-Clavell ML, et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol 2008; 102: 930-7.
7. Buchwald H, Estok R, Fahrbach K, et al. Weight and T2DM after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-56.
8. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-52.
9. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery vs. intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-77.
10. Mingrone G, Panuzi S, Gaetano A, et al. Bariatric surgery vs conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-86.
11. Lebovitz H. Type 2 diabetes mellitus, current therapies and emergence of surgical options. Nat Rev 2011; 10: 1038.
12. Hussain A, Mahmood H, El-Hasani S. Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Can J Surg 2009; 52: E269-75.
13. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518-25.
14. Dar MS, Chapman WH, Pender JR, et al. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass? Obes Surg 2012; 22: 1077-83.
15. Dellagrave G, Marchesini JC. End to side duodeno-jejunostomy with half-and-half biliopancreatic limb for the treatment of type 2 diabetes: a proposal for a simpler technique. Obes Surg 2007; 17: 138-9.
16. Stefanidis D, Kuwada TS, Gersin KS. The importance of the lengh of the limbs for gastric bypass - an evidence-based review. Obes Surg 2011; 21: 119-24.
17. Perugini RA, Malkani S. Remission of type 2 diabetes mellitus following bariatric surgery: review of mechanisms and presentation of the concept of reversibility. Curr Opin Endocrinol Diabetes Obes 2011; 18: 119-28.
18. Scopinaro N. Thirty-five years of BPD: notes on gastrointestinal physiology to complete the published information useful for better understanding and clinical use of the operation. Obes Surg 2012; 22: 427-32.
19. Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C. Biological actions of incretins GIP and GLP-1 and therapeutic perspectives in patients with T2DM. Diabetes Metab 2005; 31: 233-42.
20. Mingrone G, Castagneto-Gissey L. Mechanism of early improvement/ resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35: 518-23.
21. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanism of action. Ann Rev Med 2010; 61: 393-411.
22. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-9.
23. World Health Organization (2011) Health experts accept use of HbA1c for diagnosing diabetes. Geneva: WHO Diabetes Unit. Available at: www.who.int/diabetes
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32: 62-6.
25. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-5.
26. Proczko M, Kaska Ł, Kobiela J, et al. Roux-en-Y gastric bypass in dialysed morbidly obese patients as a preparation for a kidney transplantation: case series. Videosurgery Miniinv 2013; 8: 174-7.
27. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for non-obese type 2 diabetic patients: an interventional study with duodenal- jejunal exclusion. Obes Surg 2009; 19: 1077-83.
28. Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of T2DM in patients with BMI
29. Pattou F, Beraud G, Arnalsteen L, et al. Catering of insulinosecretion after gastric bypass in T2DM is independed from body weight loss and correlated to the increase of GLP1. Diabetes Metab 2008; 34: A23.
30. Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Rouxen- Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis 2008; 4: 521-5.
31. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in non-obese animal model of T2DM: a new perspective for an old disease. Ann Surg 2004; 239: 1-11.
32. Bose M, Olivian B, Teixeira J, et al. Do incretins play a role in the remission of T2DM after gastric bypass surgery: what are the evidences? Obes Surg 2009; 19: 217-29.
33. Grueneberger JM, Fritz T, Zhou C, et al. Long segment ileal transposition leads to early amelioration of glucose control in the diabetic obese Zucker rat. Videosurgery Miniinv 2013; 8: 130-8.
34. Paluszkiewicz R, Kalinowski P, Wroblewski T, et al. Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastrin bypass for the management of patients with morbid obesity. Videosurgery Miniinv 2012; 7: 225-32.
35. Bužga M, Holeczy P, Švagera Z, et al. Effects of sleeve gastrectomy on parameters of lipid and glucose metabolism in obese women - 6 months after operation. Videosurgery Miniinv 2013; 8: 22-8.
36. Visockiene Z, Brimas G, Abaliksta T, et al. Metabolic changes one year after laparoscopic adjustable gastric banding operation in morbidly obese subjects. Videosurgery Miniinv 2013; 8: 13-21.
37. Razak HH, Dadan J, Gołaszewski P, Safiejko K. Impact of laparoscopic sleeve gastrectomy on body mass index, ghrelin, insulin and lipid levels in 100 obese patients. Videosurgery Miniinv 2012; 7: 251-9.
38. Weiner R, Theodoridou S, Weiner S. Failure of laparoscopic sleeve gastrectomy - further procedure? Obes Facts 2011; 4 Suppl. 42-6.
39. Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005; 15: 474-81.
40. Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery vs. hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-85.
41. Kadera BE, Lum K, Grant J, et al. Remission of type 2 diabetes after RYGB is associated with greater weight loss. Surg Obes Relat Dis 2009; 5: 305-9.
42. Jastrzȩbska-Mierzyńska M, Ostrowska L, Razak HH, Dadan J. Assessment of dietary habits, nutritional status and blood biochemical parameters in patients prepared for bariatric surgery: a preliminary study. Videosurgery Miniinv 2012; 7: 156-65.
43. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245-50.
44. Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss the super obese (BMI ≥ 50 kg/m2) compared to gastric bypass. J Gastrointest Surg 2010; 14: 211-20.